102 related articles for article (PubMed ID: 23343962)
1. Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models.
Miyashita T; Shah FA; Miwa K; Sasaki S; Nishijima K; Oyama K; Ninomiya I; Fushida S; Fujimura T; Hattori T; Harmon JW; Ohta T
Digestion; 2013; 87(1):6-11. PubMed ID: 23343962
[TBL] [Abstract][Full Text] [Related]
2. Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model.
Miyashita T; Shah FA; Marti GP; Wang J; Bonde P; Gibson MK; Ohta T; Montgomery EA; Duncan M; Harmon JW
Dig Dis Sci; 2011 May; 56(5):1309-14. PubMed ID: 21053077
[TBL] [Abstract][Full Text] [Related]
3. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
[TBL] [Abstract][Full Text] [Related]
4. A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents.
Zhang T; Zhang F; Han Y; Gu Z; Zhou Y; Cheng Q; Zhu Y; Zhang C; Wang Y
Dig Dis Sci; 2007 Nov; 52(11):3202-8. PubMed ID: 17393326
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
7. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Woodall CE; Li Y; Liu QH; Wo J; Martin RC
Anticancer Drugs; 2009 Jul; 20(6):437-43. PubMed ID: 19398904
[TBL] [Abstract][Full Text] [Related]
10. [Reflux of duodenal or gastroduodenal contents induces esophageal carcinoma in rats].
Miwa K; Miyashita T; Hattori T
Nihon Rinsho; 2004 Aug; 62(8):1433-8. PubMed ID: 15344531
[TBL] [Abstract][Full Text] [Related]
11. Do proton pump inhibitors protect against cancer progression in GERD?
Miyashita T; Shah FA; Harmon JW; Marti GP; Matsui D; Okamoto K; Makino I; Hayashi H; Oyama K; Nakagawara H; Tajima H; Fujita H; Takamura H; Murakami M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Ohta T
Surg Today; 2013 Aug; 43(8):831-7. PubMed ID: 23111465
[TBL] [Abstract][Full Text] [Related]
12. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
13. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
16. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
17. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats.
Pera M; Brito MJ; Poulsom R; Riera E; Grande L; Hanby A; Wright NA
Carcinogenesis; 2000 Aug; 21(8):1587-91. PubMed ID: 10910963
[TBL] [Abstract][Full Text] [Related]
18. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats.
Miyashita T; Ohta T; Fujimura T; Ninomiya I; Fushida S; Hattori T; Miwa K
Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model.
Babu A; Meng X; Banerjee AM; Gamboni-Robertson F; Cleveland JC; Damle S; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1220-7. PubMed ID: 18544357
[TBL] [Abstract][Full Text] [Related]
20. Low dose aspirin prevents duodenoesophageal reflux induced mucosal changes in wistar rat esophagus by MAP kinase mediated pathways.
Selvan B; Ramachandran A; Korula A; Amirtharaj GJ; Kettimuthu K; Nair S; Nair A; Samuel P; Mathew G
Int J Surg; 2012; 10(2):73-9. PubMed ID: 22197650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
